Apigenin inhibits tumor necrosis factor α-induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells

Lab / animal OA: bronze CC0 ⤵ 16 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Apigenin was found to inhibit tumor necrosis factor α–induced cell proliferation and prostaglandin E2 synthesis in endometriotic stromal cells by inactivating NFκB.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Apigenin suppressed tumor necrosis factor α-induced cell proliferation and prostaglandin E2 expression via the attenuation of nuclear factor κB pathway in endometriotic stromal cells in vitro. Apigenin reduced the mitogenic activity and inflammatory reaction in endometriotic stromal cells.

My notes (saved in your browser only)

MeSH descriptors

Apigenin Dinoprostone Endometrium Endometrium Growth Inhibitors NF-kappa B Tumor Necrosis Factor-alpha Adult Apigenin Cell Proliferation Cell Proliferation Cells, Cultured Dinoprostone Dinoprostone Endometrium Endometrium Female Growth Inhibitors Humans NF-kappa B

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (22)

Cited by (22)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:08:15.389298+00:00
License: CC0 · commercial use OK